» Articles » PMID: 19567599

Inhaled Corticosteroids in COPD: the Case Against

Overview
Journal Eur Respir J
Specialty Pulmonary Medicine
Date 2009 Jul 2
PMID 19567599
Citations 49
Authors
Affiliations
Soon will be listed here.
Citing Articles

Minimising inhaled corticosteroids for COPD.

Heran B, Perry T, Bassett K Afr J Prim Health Care Fam Med. 2025; 16(1):e1-e3.

PMID: 39846112 PMC: 11736534. DOI: 10.4102/phcfm.v16i1.4756.


Effect of long-term inhaled corticosteroids therapy on cognitive function in patients with bronchial asthma and chronic obstructive pulmonary disease.

Sharma S, Karki D, Julitta K Lung India. 2024; 41(5):357-361.

PMID: 39215978 PMC: 11472989. DOI: 10.4103/lungindia.lungindia_399_23.


Special Issue "Diagnosis, Treatment, and Management of COPD and Asthma".

Nishimura K Diagnostics (Basel). 2023; 13(16).

PMID: 37627892 PMC: 10453548. DOI: 10.3390/diagnostics13162634.


Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease.

Fukuda N, Horita N, Kaneko A, Goto A, Kaneko T, Ota E Cochrane Database Syst Rev. 2023; 6:CD012066.

PMID: 37276335 PMC: 10241721. DOI: 10.1002/14651858.CD012066.pub3.


Verproside, the Most Active Ingredient in YPL-001 Isolated from var. , Decreases Inflammatory Response by Inhibiting PKCδ Activation in Human Lung Epithelial Cells.

Oh E, Ryu H, Kim M, Lee J, Song Y, Park J Int J Mol Sci. 2023; 24(8).

PMID: 37108390 PMC: 10138391. DOI: 10.3390/ijms24087229.